Amin Salehpour
Overview
Explore the profile of Amin Salehpour including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neshatbini Tehrani A, Hatami B, Daftari G, Hekmatdoost A, Yari Z, Salehpour A, et al.
BMC Public Health
. 2024 May;
24(1):1362.
PMID: 38773414
Background: Non-alcoholic fatty liver disease (NAFLD) accounts as a crucial health concern with a huge burden on health and economic systems. The aim of this study is to evaluate the...
2.
Neshatbini Tehrani A, Hatami B, Helli B, Yari Z, Daftari G, Salehpour A, et al.
Sci Rep
. 2024 Mar;
14(1):5134.
PMID: 38429385
A two-arm randomized open labeled controlled clinical trial was conducted on 50 patients with non-alcoholic fatty liver disease (NAFLD). Subjects were randomized to either receive two tablets of soy isoflavone...
3.
Daftari G, Neshatbini Tehrani A, Pashayee-Khamene F, Karimi S, Ahmadzadeh S, Hekmatdoost A, et al.
BMC Gastroenterol
. 2023 Jul;
23(1):227.
PMID: 37400778
Background: Liver cirrhosis is a worldwide burden and is associated with poor clinical outcomes, including increased mortality. The beneficial effects of dietary modifications in reducing morbidity and mortality are inevitable....
4.
Neshatbini Tehrani A, Saadati S, Yari Z, Salehpour A, Sadeghi A, Daftari G, et al.
BMC Gastroenterol
. 2023 Apr;
23(1):119.
PMID: 37041462
Background: Gallstone disease (GSD) and its complications are major public health issues globally. Although many community-based studies had addressed the risk factors for GSD, little is known about the associations...
5.
Salehpour A, Hedayati M, Shidfar F, Neshatbini Tehrani A, Farshad A, Mohammadi S
Nutr Metab (Lond)
. 2021 Apr;
18(1):42.
PMID: 33858473
No abstract available.
6.
Salehpour A, Shidfar F, Hedayati M, Farshad A, Neshatbini Tehrani A, Mohammadi S
Diabetol Metab Syndr
. 2021 Apr;
13(1):41.
PMID: 33836827
Background: Obesity is considered a major health concern and mounting evidence suggests that the exposure to environmental endocrine disruptors, including Bisphenol-A (BPA), may enhance the risk to develop the disease....
7.
Salehpour A, Hedayati M, Shidfar F, Neshatbini Tehrani A, Farshad A, Mohammadi S
Nutr Metab (Lond)
. 2021 Mar;
18(1):29.
PMID: 33712053
Purpose: 1,25-dihydroxyvitamin D3 may regulate adipogenesis in adipocytes in-vitro, but little is known about possible molecular mechanisms related to the inhibitory effect of 1,25-dihydroxyvitamin D3 on adipogenesis in humans҆ adipose...
8.
Farhadnejad H, Neshatbini Tehrani A, Salehpour A, Hekmatdoost A
Clin Nutr ESPEN
. 2020 Nov;
40:257-262.
PMID: 33183546
Background And Aim: The relation of some antioxidant nutrients with psychological disorders has been studied previously. The aim of this study was to examine the association between antioxidant vitamin intakes...
9.
Salehpour A, Shidfar F, Hedayati M, Neshatbini Tehrani A, Farshad A, Mohammadi S
Genes Environ
. 2020 Mar;
42:13.
PMID: 32175033
Background: The endocrine disruptor Bisphenol-A (BPA), has been involved in dysregulating adipose tissue development and increasing the risk of obesity. The objective of this experiment was to investigate whether treatment...
10.
Neshatbini Tehrani A, Farhadnejad H, Salehpour A, Beyzai B, Hekmatdoost A, Rashidkhani B
Int J Adolesc Med Health
. 2019 Apr;
33(4).
PMID: 30978172
Background: Adherence to a Mediterranean dietary pattern (MDP) has been reported to decrease chronic diseases. Objective: The aim of the present study was to determine the association between nutrition knowledge...